Skip to content

Alumis Inc. ALMS Total Operating Expenses

Total Operating Expenses at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$36.43M+45.2%
Immunome logo
ImmunomeIMNM
$59.33M+24.7%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$60.19M+8.8%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$47M+36.9%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$60.02M+26.0%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$118.52M+22.8%

Segments

By segment

See full
Single Reportable$100.15M-15.8%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.12B+739%
Enterprise value$3.1B+1,238%
P/S371.9×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alumis Inc.'s total operating expenses?
Alumis Inc. (ALMS) reported total operating expenses of $100.15M in Q1 2026.
How has Alumis Inc.'s total operating expenses changed year-over-year?
Alumis Inc.'s total operating expenses decreased by 15.8% year-over-year, from $118.92M to $100.15M.
What is the long-term trend for Alumis Inc.'s total operating expenses?
Over 2 years (2023 to 2025), Alumis Inc.'s total operating expenses has grown at a 73.8% compound annual growth rate (CAGR), from $158.17M to $477.85M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.